# US 8,277,821 B2 · Immunizing compositions and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,821 B2
- Document ID: US8277821B2
- Status: Granted
- Kind: B2
- Application number: 13/091,911
- Filed: 2011-04-21
- Published: 2011-08-18
- Granted: 2012-10-02
- Earliest claimed: 2001-01-03
- Assignees: Epitopix, LLC
- Inventors: Daryll A. Emery; Darren E. Straub
- Web page: https://patentgrep.com/patent/US8277821B2

## Abstract

The present invention provides compositions including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter. The present invention also provides methods of making and methods of using such compositions.

## Claims

### Claim 1

A method for inducing the production of an antibody that specifically binds at least one SRP in a human, the method comprising administering to a human an effective amount of a composition comprising:
at least two SRPs isolated from a gram negative microbe;
LPS at a concentration of no greater than about 10.0 EU/ml; and
a pharmaceutically acceptable carrier, wherein the composition induces in the human antibody that specifically binds at least one SRP.

### Claim 2 (depends on 1)

The method of claim 1 wherein the gram negative microbe is an enteropathogen.

### Claim 3 (depends on 1)

The method of claim 1 wherein the gram negative microbe is a member of the family Enterobacteriaceae, family Vibrionaceae, family Pasteurellaceae, or family Pseudomonadaceae.

### Claim 4 (depends on 1)

The method of claim 1 wherein the gram negative microbe is a member of the tribe Escherichieae or Salmonelleae.

### Claim 5 (depends on 1)

The method of claim 1 wherein the gram negative microbe is Salmonella spp., Escherichia coli, Actinobacillus spp., Haemophilus spp., or Campylobacter spp.

### Claim 6 (depends on 1)

The method of claim 1 wherein the at least two SRPs have molecular weights of between about 60 kDa and about 100 kDa as determined by sodium dodecyl-polyacrylamide gel electrophoresis.

### Claim 7 (depends on 1)

The method of claim 1 further comprising at least one porin having a molecular weight of between about 30 kDa and about 43 kDa as determined by sodium dodecyl-polyacrylamide gel electrophoresis.

### Claim 8 (depends on 3)

The method of claim 3 wherein the member of the family Enterobacteriaceae is Shigella spp., Proteus spp., Klebsiella spp., Serratia spp., or Yersinia spp.

### Claim 9 (depends on 3)

The method of claim 3 wherein the member of the family Vibrionaceae is Vibrio cholerae.

### Claim 10 (depends on 3)

The method of claim 3 wherein the member of the family Pasteurellaceae is Pasturella spp.

### Claim 11 (depends on 10)

The method of claim 10 wherein the Pasturella spp, is Pasturella multocida or Pasteurella haemolytica.

### Claim 12 (depends on 3)

The method of claim 3 wherein the member of the family Pseudomonadaceae is Pseudomonas spp.

### Claim 13 (depends on 12)

The method of claim 12 wherein the Pseudomonas spp. is Pseudomonas aeruginosa.

### Claim 14 (depends on 1)

The method of claim 1 wherein the gram negative microbe is a first gram negative microbe, wherein the antibody specifically binds an SRP present on the surface of a second gram negative microbe.

### Claim 15 (depends on 14)

The method of claim 14 wherein the second gram negative microbe is an enteropathogen.

### Claim 16 (depends on 14)

The method of claim 14 wherein the second gram negative microbe is a member of the family Enterobacteriaceae, family Vibrionaceae, family Pasteurellaceae, or family Pseudomonadaceae.

### Claim 17 (depends on 16)

The method of claim 16 wherein the member of the family Enterobacteriaceae is Shigella spp., Proteus spp., Klebsiella spp., Serratia spp., or Yersinia spp.

### Claim 18 (depends on 16)

The method of claim 16 wherein the member of the family Vibrionaceae is Vibrio cholerae.

### Claim 19 (depends on 16)

The method of claim 16 wherein the member of the family Pasteurellaceae is Pasturella spp.

### Claim 20 (depends on 19)

The method of claim 19 wherein the Pasturella spp, is Pasturella multocida or Pasteurella haemolytica.

### Claim 21 (depends on 16)

The method of claim 16 wherein the member of the family Pseudomonadaceae is Pseudomonas spp.

### Claim 22 (depends on 21)

The method of claim 21 wherein the Pseudomonas spp, is Pseudomonas aeruginosa.

### Claim 23 (depends on 14)

The method of claim 14 wherein the first and second gram negative microbes are different species.

### Claim 24 (depends on 14)

The method of claim 14 wherein the first and second gram negative microbes are different genera.

### Claim 25 (depends on 14)

The method of claim 14 wherein the second gram negative microbe is a member of the tribe Escherichieae or Salmonelleae.

### Claim 26 (depends on 14)

The method of claim 14 wherein the second gram negative microbe is Salmonella spp., Escherichia coli, Actinobacillus spp., Haemophilus spp., or Campylobacter spp.

### Claim 27 (depends on 1)

The method of claim 1 wherein the human has or is at risk of having a gram negative infection.

### Claim 28 (depends on 1)

The method of claim 1 wherein the method further comprises collecting the antibody.

### Claim 29 (depends on 28)

The method of claim 28 wherein the method further comprises administering the collected antibody to a second human.

### Claim 30 (depends on 29)

The method of claim 29 wherein the administering the collected antibody comprises administration of colostrum to the second human.

### Claim 31 (depends on 28)

The method of claim 28 wherein the collecting comprises collecting serum, plasma, blood, or colostrum.

### Claim 32 (depends on 1)

The method of claim 1 wherein the method further comprises isolating the antibody.

### Claim 33

A method for inducing the production of an antibody that specifically binds at least one SRP in a human, the method comprising administering to a human an effective amount of a siderophore receptor polypeptide (SRP) composition comprising:
at least two SRPs isolated from a gram negative microbe;
lipopolysaccharide (LPS) at a concentration of no greater than the concentration of LPS in a reference composition comprising: the at least two siderophore receptor polypeptides isolated from the gram negative microbe and lipopolysaccharide; wherein the reference composition is produced by a process comprising:
providing the gram negative microbe;
disrupting the gram negative microbe in a buffer;
solubilizing the disrupted gram negative microbe for greater than about 24 hours in a solution comprising sarcosine to result in solubilized and insoluble cellular material, wherein a ratio of the sarcosine to gram weight of disrupted gram negative microbe is between about 0.8 gram sarcosine per about 4.5 grams of disrupted gram negative microbe and about 1.2 grams sarcosine per about 4.5 grams of disrupted gram negative microbe; and
isolating molecules of the gram negative microbe, wherein the isolated molecules comprise the at least two SRPs and LPS; and
a pharmaceutically acceptable carrier, wherein the SRP composition induces in the human antibody that specifically binds at least one SRP.

### Claim 34 (depends on 33)

The method of claim 33 wherein the gram negative microbe is an enteropathogen.

### Claim 35 (depends on 33)

The method of claim 33 wherein the gram negative microbe is a member of the family Enterobacteriaceae, family Vibrionaceae, family Pasteurellaceae, or family Pseudomonadaceae.

### Claim 36 (depends on 33)

The method of claim 33 wherein the gram negative microbe is a member of the tribe Escherichieae or Salmonelleae.

### Claim 37 (depends on 33)

The method of claim 33 wherein the gram negative microbe is Salmonella spp., Escherichia coli, Actinobacillus spp., Haemophilus spp., or Campylobacter spp.

### Claim 38 (depends on 33)

The method of claim 33 wherein the at least two SRPs have molecular weights of between about 60 kDa and about 100 kDa as determined by separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

### Claim 39 (depends on 33)

The method of claim 33 wherein the SRP composition further comprises at least one porin having a molecular weight of between about 30 kDa and about 43 kDa as determined by separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

### Claim 40 (depends on 35)

The method of claim 35 wherein the member of the family Enterobacteriaceae is Shigella spp., Proteus spp., Klebsiella spp., Serratia spp., or Yersinia spp.

### Claim 41 (depends on 35)

The method of claim 35 wherein the member of the family Vibrionaceae is Vibrio cholerae.

### Claim 42 (depends on 35)

The method of claim 35 wherein the member of the family Pasteurellaceae is Pasturella spp.

### Claim 43 (depends on 42)

The method of claim 42 wherein the Pasturella spp, is Pasturella multocida or Pasteurella haemolytica.

### Claim 44 (depends on 35)

The method of claim 35 wherein the member of the family Pseudomonadaceae is Pseudomonas spp.

### Claim 45 (depends on 44)

The method of claim 44 wherein the Pseudomonas spp. is Pseudomonas aeruginosa.

### Claim 46 (depends on 33)

The method of claim 33 wherein the gram negative microbe is a first gram negative microbe, wherein the antibody specifically binds an SRP present on the surface of a second gram negative microbe.

### Claim 47 (depends on 46)

The method of claim 46 wherein the second gram negative microbe is an enteropathogen.

### Claim 48 (depends on 46)

The method of claim 46 wherein the second gram negative microbe is a member of the family Enterobacteriaceae, family Vibrionaceae, family Pasteurellaceae, or family Pseudomonadaceae.

### Claim 49 (depends on 48)

The method of claim 48 wherein the member of the family Enterobacteriaceae is Shigella spp., Proteus spp., Klebsiella spp., Serratia spp., or Yersinia spp.

### Claim 50 (depends on 48)

The method of claim 48 wherein the member of the family Vibrionaceae is Vibrio cholerae.

### Claim 51 (depends on 48)

The method of claim 48 wherein the member of the family Pasteurellaceae is Pasturella spp.

### Claim 52 (depends on 51)

The method of claim 51 wherein the Pasturella spp, is Pasturella multocida or Pasteurella haemolytica.

### Claim 53 (depends on 48)

The method of claim 48 wherein the member of the family Pseudomonadaceae is Pseudomonas spp.

### Claim 54 (depends on 53)

The method of claim 53 wherein the Pseudomonas spp. is Pseudomonas aeruginosa.

### Claim 55 (depends on 48)

The method of claim 48 wherein the first and second gram negative microbes are different species.

### Claim 56 (depends on 48)

The method of claim 48 wherein the first and second gram negative microbes are different genera.

### Claim 57 (depends on 48)

The method of claim 48 wherein the second gram negative microbe is a member of the tribe Escherichieae or Salmonelleae.

### Claim 58 (depends on 48)

The method of claim 48 wherein the second gram negative microbe is Salmonella spp., Escherichia coli, Actinobacillus spp., Haemophilus spp., or Campylobacter spp.

### Claim 59 (depends on 48)

The method of claim 48 wherein the human has or is at risk of having a gram negative infection.

### Claim 60 (depends on 48)

The method of claim 48 wherein the method further comprises collecting the antibody.

### Claim 61 (depends on 60)

The method of claim 60 wherein the method further comprises administering the collected antibody to a second human.

### Claim 62 (depends on 60)

The method of claim 60 wherein the administering the collected antibody comprises administration of colostrum to the second human.

### Claim 63 (depends on 60)

The method of claim 60 wherein the collecting comprises collecting serum, plasma, blood, or colostrum.

### Claim 64 (depends on 33)

The method of claim 33 wherein the method further comprises isolating the antibody.

### Claim 65 (depends on 1)

The method of claim 1 wherein the concentration of LPS of the composition is determined by a gel-clot test comprising a Limulus amebocyte lysate.

### Claim 66 (depends on 65)

The method of claim 65 wherein the gel-clot test comprises contacting the composition with a lysate of horseshoe crab circulating amebocytes to form a mixture, wherein the pH of the composition is between 6 and 8, incubating the mixture for about 1 hour at about 37° C., and determining if there is gelation, wherein gelation indicates the presence of LPS.

### Claim 67 (depends on 33)

The method of claim 33 wherein the concentration of LPS of the composition is determined by a gel-clot test comprising a Limulus amebocyte lysate.

### Claim 68 (depends on 67)

The method of claim 67 wherein the gel-clot test comprises contacting the composition with a lysate of horseshoe crab circulating amebocytes to form a mixture, wherein the pH of the composition is between 6 and 8, incubating the mixture for about 1 hour at about 37° C., and determining if there is gelation, wherein gelation indicates the presence of LPS.
